Jonathan Gershoni

from Wikipedia, the free encyclopedia

Jonathan Michael Gershuni (* 1950 in Haifa ) is an Israeli virologist and university professor. He is a professor at Tel Aviv University . His research focus is the development of antidotes for diseases such as AIDS , hepatitis C , influenza , SARS and MERS .

Live and act

Jonathan Gershoni was born in Haifa in 1950.

He did his Bachelor of Science in biology at the Hebrew University of Jerusalem and then did research at the Yale School of Medicine in the USA. From 1983 he worked in Israel at the Weizmann Institute for Science .

In Bethesda , he conducted research on the AIDS virus at the National Institutes of Health . He was one of the founders of the Department of Cell Research and Immunology at Tel Aviv University and its chairman from 2003 to 2006.

During the COVID-19 pandemic, he received a patent in the USA in mid-April 2020 for a mechanism that rebuilds the Receptor Binding Motif (RBM) of the SARS-CoV-2 virus, making it more vulnerable to the immune system.

family

Jonathan Gershoni is married and has three daughters.

Web links

Individual evidence

  1. ↑ a b c "INTERNATIONAL SOCIETY FOR VACCINES 2018 ANNUAL CONGRESS" isv-online.org, viewed on April 20, 2020
  2. ^ "Resonant Cavity Imaging: A Means Toward High-Throughput Label-Free Protein Detection" ncbi.nlm.nih.gov 2008, accessed April 20, 2020
  3. ↑ US grants Israeli prof. patent for tech that could lead to virus vaccine on the Times of Israel website April 20, 2020.
  4. ↑ Jonathan Gershoni on the Tel Aviv University website, viewed April 20, 2020
personal data
SURNAME Gershoni, Jonathan
ALTERNATIVE NAMES Gershoni, Jonathan M .; Gershuni, Jonathan Michael (full name)
BRIEF DESCRIPTION Israeli virologist and university professor
DATE OF BIRTH 1950
PLACE OF BIRTH Haifa